![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/335 | |
A61K 9/00 | |||
A61P 27/14 | |||
A61K 9/08 | |||
A61K 47/10 | |||
A61K 47/32 | |||
A61K 47/40 | |||
A61K 47/48 |
(11) | Number of the document | 2709610 |
(13) | Kind of document | T |
(96) | European patent application number | 12725950.5 |
Date of filing the European patent application | 2012-05-18 | |
(97) | Date of publication of the European application | 2014-03-26 |
(45) | Date of publication and mention of the grant of the patent | 2016-05-18 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2012/038663 |
Date | 2012-05-18 |
(87) | Number | WO 2012/159064 |
Date | 2012-11-22 |
(30) | Number | Date | Country code |
201161487789 P | 2011-05-19 | US | |
201161548957 P | 2011-10-19 | US |
(72) |
GAMACHE, Daniel A., US
ALANI, Laman, US
GHOSH, Malay, US
GAL N, Francisco Javier, ES
PERDIGUER, N ria, ES
SINGH, Onkar, US
|
(73) |
Alcon Research, Ltd.,
6201 South Freeway, Mail Code TB4-8, Fort Worth, TX 76134-2099,
US
|
(54) | HIGH CONCENTRATION OLOPATADINE OPHTHALMIC COMPOSITION |
HIGH CONCENTRATION OLOPATADINE OPHTHALMIC COMPOSITION |